Phase II study of dabrafenib and trametinib following progression on BRAF inhibitor monotherapy in metastaticmelanoma: Exploration of clinical and molecular predictors of response.
Year: 2015
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Jennifer Leigh McQuade, Guo Chen, David J Panka, Alexandre Reuben, Roland L. Bassett, Aron Joon, Alexander J. F. Lazar, Michael T. Tetzlaff, Lauren Simpson, Rosalind Mouton, Sapna Pradyuman Patel, Isabella Claudia Glitza, Wen-Jen Hwu, Rodabe Navroze Amaria, Adi Diab, Patrick Hwu, Jennifer Ann Wargo, Ryan J. Sullivan, Kevin Kim, Michael A. Davies
Language: English
Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2597899591